SCHEMBL6710187

SCHEMBL6710187

Cn1c(C(=O)Nc2ccc(Cl)cc2-c2noc(=O)[nH]2)cc2c(Br)ccc(NC(=O)Cc3ccccc3)c21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F11 P03951 3/20 0.40
GRIK1 P39086 1/20 0.40
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
ALDH1A1 P00352 3/20 0.36
L3MBTL1 Q9Y468 3/20 0.36
GAA P10253 2/20 0.36
LMNA P02545 1/20 0.36
KDM4E B2RXH2 2/20 0.35
MAPK1 P28482 1/20 0.35
POLB P06746 1/20 0.35
RXFP1 Q9HBX9 2/20 0.34
PKM P14618 1/20 0.34
TSHR P16473 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
TP53 P04637 1/20 0.34
MAPT P10636 1/20 0.34
PARP14 Q460N5 1/20 0.34
RORC P51449 1/20 0.34
PSD A5PKW4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6710409 0.92 GRIK1 (0.36) F11GRIK1MEN1KMT2AALDH1A1
SCHEMBL6709860 0.91 GRIK1 (0.39) F11GRIK1MEN1KMT2AALDH1A1
SCHEMBL6709930 0.89 PARP14 (0.37) ALDH1A1GAALMNAKDM4ETP53
SCHEMBL6710388 0.85 L3MBTL1 (0.38) MEN1KMT2AALDH1A1L3MBTL1GAA
SCHEMBL6707810 0.84 GRIK1 (0.42) F11GRIK1RXFP1TP53MAPT
SCHEMBL6711947 0.84 GRIK1 (0.35) GRIK1MEN1KMT2AALDH1A1L3MBTL1
SCHEMBL6713762 0.81 GRIK1 (0.38) GRIK1ALDH1A1RXFP1TSHRTP53
SCHEMBL6707799 0.81 RORC (0.35) F11GRIK1LMNAKDM4EPOLB
SCHEMBL6709886 0.81 GRIK1 (0.42) F11GRIK1RXFP1TP53MAPT
SCHEMBL6919458 0.81 KDM4E (0.34) F11GRIK1ALDH1A1GAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 F11 1797/4885GRIK1 3885/4885MEN1 4100/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.